SCHEMBL9748575

SCHEMBL9748575

Clc1ccc(-c2nc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3)[nH]2)cc1

nearest known ligand 0.83

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 14/20 0.83
MAPK12 P53778 14/20 0.83
MAPK11 Q15759 14/20 0.83
MAPK14 Q16539 14/20 0.83
GCGR P47871 12/20 0.83
RAF1 P04049 4/20 0.73
CYP19A1 P11511 1/20 0.60
MAPK9 P45984 2/20 0.57
PRKD3 O94806 1/20 0.57
MAP4K4 O95819 1/20 0.57
FRK P42685 1/20 0.57
CSNK1A1 P48729 1/20 0.57
CSNK1D P48730 1/20 0.57
GSK3B P49841 1/20 0.57
PTK6 Q13882 1/20 0.57
PRKD2 Q9BZL6 1/20 0.57
CLK4 Q9HAZ1 1/20 0.57
NOX1 Q9Y5S8 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3956357 0.94 MAPK13 (0.74) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL2127491 0.93 MAPK13 (0.85) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6469052 0.91 MAPK13 (0.73) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL2649730 0.91 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6471005 0.91 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL29587593 0.91 CYP19A1 (0.72) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6464698 0.87 NOX1 (0.74) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL5921859 0.86 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6469111 0.86 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6469126 0.84 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11963948-B1 2-(4-chlorophenyl)-4,5-bis(4-chlorophenyl)-1H-imidazole as an antimicrobial compound King Faisal University (SA) 2024-04-23 US claimed
US-11963948-B1 2-(4-chlorophenyl)-4,5-bis(4-chlorophenyl)-1H-imidazole as an antimicrobial compound King Faisal University (SA) 2024-04-23 US disclosed
US-11963948-B1 2-(4-chlorophenyl)-4,5-bis(4-chlorophenyl)-1H-imidazole as an antimicrobial compound King Faisal University (SA) 2024-04-23 US disclosed
US-11963948-B1 2-(4-chlorophenyl)-4,5-bis(4-chlorophenyl)-1H-imidazole as an antimicrobial compound King Faisal University (SA) 2024-04-23 US disclosed
EP-0236628-B1 INHIBITION OF THE 5-LIPOXYGENASE PATHWAY SMITHKLINE BEECHAM CORPORATION (US) 1992-12-02 EP disclosed
US-4780470-A WITH 4,5-DIALKYL-2(SUBSTITUTED)IMIDAZOLE SMITHKLINE BECKMAN CORPORATION (US) 1988-10-25 US disclosed
EP-0236628-A1 Inhibition of the 5-lipoxygenase pathway SMITHKLINE BEECHAM CORPORATION (US) 1987-09-16 EP disclosed
US-4686231-A 4,5-DIARYL-2-SUBSTITUTED-IMIDAZOLE SMITHKLINE BECKMAN CORPORATION (US) 1987-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11963948-B1 2-(4-chlorophenyl)-4,5-bis(4-chlorophenyl)-1H-imidazole as an antimicrobial compound IL4, CASP4, TLR4 MAPK13 1792/4885MAPK12 1593/4885MAPK11 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.